激光屈光手术在孕妇或哺乳期患者中的应用。

Laser refractive surgery in pregnant or breastfeeding patients.

机构信息

From the Department of Ophthalmology, Regional University Hospital of Malaga, Malaga, Spain (Zamorano-Martín, García-Lorente, Rachwani-Anil); Department of Physics of Condensed Matter, Optics Area, University of Seville, Seville, Spain (Sánchez-González); Department of Ophthalmology (Tecnolaser Clinic Vision), Refractive Surgery Centre, Seville, Spain (Sánchez-González); Department of Ophthalmology, Hospital Clinic de Barcelona, Barcelona, Spain (Peraza-Nieves); Department of Doctoral Studies, Riga Stradins University, Riga, Latvia (Borroni); Department of Ophthalmology, Royal Liverpool University Hospital, Liverpool, United Kingdom (Borroni); Department of Ophthalmology, Hospital Universitario Virgen de las Nieves, Granada, Spain (Rocha-de-Lossada); Department of Ophthalmology, University of Malaga, Malaga, Spain (Rocha-de-Lossada).

出版信息

J Cataract Refract Surg. 2021 Aug 1;47(8):1081-1087. doi: 10.1097/j.jcrs.0000000000000606.

DOI:10.1097/j.jcrs.0000000000000606

PMID:34292893

Abstract

This systematic review reported the outcomes of laser corneal refractive surgery in pregnant or breastfeeding patients. This study was performed by searching in PubMed, Web of Science, and Scopus databases, on June 15, 2020. Included were 128 eyes from a total of 64 patients, with the mean maximum follow-up was 39.2 ± 36.14 months. Time from surgery to complication ranged from 1 to 67 months, with a mean value of 23.42 ± 22.23 months. Photorefractive keratectomy and laser in situ keratomileusis surgery seem to be stable procedures that are not modified during pregnancy and safe to complete during breastfeeding. Nevertheless, the lack of weight prospective research avoids having a greater certainty on this matter, and because of transitory nature of pregnancy and breastfeeding, it could still be contemplated that surgery risk outweigh the benefits. Additional investigation will be necessary to clarify these issues.

摘要

本系统评价报告了激光角膜屈光手术在妊娠或哺乳期患者中的结果。本研究于 2020 年 6 月 15 日在 PubMed、Web of Science 和 Scopus 数据库中进行了检索。共纳入 64 例患者的 128 只眼，平均最长随访时间为 39.2±36.14 个月。从手术到并发症的时间范围为 1 至 67 个月，平均为 23.42±22.23 个月。准分子激光角膜切削术和激光原位角膜磨镶术似乎是稳定的手术，在妊娠期间不会改变，并且在哺乳期完成是安全的。然而，由于缺乏前瞻性研究，因此在这方面不能有更大的把握，而且由于妊娠和哺乳期是短暂的，仍有可能认为手术风险大于益处。需要进一步的研究来阐明这些问题。